RXO’s (RXO) “Hold” Rating Reiterated at Benchmark

Benchmark reaffirmed their hold rating on shares of RXO (NYSE:RXOFree Report) in a research note released on Wednesday,Benzinga reports.

RXO has been the topic of a number of other reports. Citigroup cut shares of RXO from a “buy” rating to a “neutral” rating and set a $33.00 price target on the stock. in a research note on Tuesday, November 12th. Wells Fargo & Company lowered their price target on shares of RXO from $31.00 to $28.00 and set an “equal weight” rating for the company in a research note on Tuesday, January 7th. Jefferies Financial Group reduced their price objective on RXO from $33.00 to $30.00 and set a “buy” rating on the stock in a research note on Friday, January 10th. Susquehanna lowered their target price on RXO from $16.00 to $12.00 and set a “negative” rating for the company in a research note on Tuesday, November 12th. Finally, The Goldman Sachs Group restated a “neutral” rating and set a $29.00 price target on shares of RXO in a research report on Monday, November 18th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $26.77.

Read Our Latest Report on RXO

RXO Stock Down 1.5 %

Shares of RXO opened at $25.18 on Wednesday. The firm has a 50 day simple moving average of $26.82 and a two-hundred day simple moving average of $27.79. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.33 and a quick ratio of 1.33. RXO has a one year low of $18.75 and a one year high of $32.82. The company has a market cap of $4.05 billion, a P/E ratio of -12.72, a P/E/G ratio of 3.17 and a beta of 1.52.

RXO (NYSE:RXOGet Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.01. The company had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $956.19 million. RXO had a positive return on equity of 1.64% and a negative net margin of 6.81%. RXO’s revenue was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.05 EPS. Research analysts forecast that RXO will post 0.11 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the company. Wilmington Savings Fund Society FSB purchased a new position in RXO in the 3rd quarter worth approximately $28,000. Nomura Asset Management Co. Ltd. increased its holdings in shares of RXO by 68.7% in the 3rd quarter. Nomura Asset Management Co. Ltd. now owns 1,400 shares of the company’s stock worth $39,000 after purchasing an additional 570 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of RXO by 407.0% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,800 shares of the company’s stock worth $43,000 after purchasing an additional 1,445 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of RXO by 40.0% in the third quarter. GAMMA Investing LLC now owns 1,784 shares of the company’s stock worth $50,000 after purchasing an additional 510 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new position in shares of RXO during the second quarter valued at $112,000. Institutional investors own 92.73% of the company’s stock.

RXO Company Profile

(Get Free Report)

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.

Featured Stories

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.